Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other top dividend ...

Here are four perfect high-yield dividend stock picks for investors looking to follow the lead of the top money managers on ...

Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing 530% to $0.63. Explore more details here.

We’re in a somewhat unusual economic predicament right now. On one hand, inflation remains high (at least compared to the ...

We recently published a list of Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other top dividend contenders.

Luckily, there's a well-established, dividend-paying business offering an ultra-high yield above 6% at recent prices. Pfizer (NYSE: PFE) stock has been trading well below its previous peak ...